Monographie - Alfentanil hydrochloride

Последно актуализиране :
05/12/2025

Alfentanil hydrochloride

Химична структура

Търговско наименование

Търговските имена са примерни и съставът на помощните вещества може да бъде различен в зависимост от държавата и лабораториите

Alfast	Бразилия
Alfenta	Иран, Перу, Съединени Американски щати / САЩ
Alfentanil	Великобритания, Германия, Дания, Иран, Канада, Колумбия, Съединени Американски щати / САЩ, Финландия, Франция, Чили
Alfiject	Иран
Limifen	Испания
Rapifen	Австрия, Белгия, Великобритания, Германия, Гърция, Дания, Египет, Иран, Ирландия, Люксенбург, Малайзия, нова Зеландия, Норвегия, Полша, Португалия, Саудитска Арабия, Словения, Тунис, Финландия, Франция, Холандия, Швейцария, Швеция

Библиография : Alfentanil hydrochloride

	Вид	Публикация
59	Списание	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
299	Списание	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300	Списание	Trissel LA, Gilbert DL, Martinez JF. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319	Списание	Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999.
660	Списание	Michaels MR, Stauffer GL, Haas DP. Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility. Ann Pharmacotherapy 1996 ; 30: 228-232.
815	Списание	Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL. Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
921	Списание	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
1625	Списание	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1712	Списание	Trissel LA, Saenz CA. Compatibility screening of Precedex during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 230-233.
1713	Списание	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
1721	Списание	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1803	Списание	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
1861	Списание	Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J. Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture. Int J Pharm 1996 ; 127: 255-259.
1925	Списание	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
2086	Списание	Sharley NA, Burgess NG. Stability and compatibility of alfentanil hydrochloride and morphine sulfate in poypropylene syringes. J Pharm Pract and Res 2003 ; 33: 279-281.
3380	Списание	Eckle V-S, Heim E, Hahn M, Grasshoff C. Incompatibility of Piritramide with Cephalosporins. Ann Pharmacotherapy 2013 ;47:426-427.
3502	Лаборатория	Propofol (Diprivan®) - Summary of Products Characteristics Astra Zeneca 2012
3504	Лаборатория	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012
3601	Лаборатория	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012
4952	Лаборатория	Alfentanil 5 mg/ml solution for injection - Summary of Product Characteristics Updated 19-Oct-2022 \| hameln pharma ltd Hameln pharma ltd 2022
4993	Лаборатория	MIVACRON 20 mg/10 ml, solution injectable (IV) - Résumé des caractéristiques du produit. ASPEN PHARMA TRADING LIMITED

Mentions Légales